Corcept Therapeutics reported $97.47M in Gross Profit on Sales for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
TG Therapeutics TGTX:US 2.11M 373K
Acadia Pharmaceuticals ACAD:US $ 112.52M 15.68M
Ani Pharmaceuticals ANIP:US $ 30.21M 3.18M
Aurora Cannabis Inc ACB:CN -36371000 50.47M
Biomarin Pharmaceutical BMRN:US $ 402.39M 72.33M
Bristol Myers Squibb BMY:US $ 9177M 452M
Canopy Growth Corp WEED:CN C$ 10.09M 81.23M
Corcept Therapeutics CORT:US $ 97.47M 2.61M
Depomed DEPO:US $ 22.42M 0.97M
Eli Lilly And LLY:US $ 5737.9M 211.8M
Esperion Therapeutics ESPR:US $ 11.71M 1.38M
Johnson & Johnson JNJ:US $ 15828M 1021M
Knight Therapeutics Inc GUD:CN C$ 32.48M 5.29M
Lannett LCI:US $ 3.08M 2.63M
Merk MRK:US $ 10567M 873M
Nektar Therapeutics NKTR:US $ 18.85M 0.76M
Novartis NOVN:VX 9.52B 3M
Novartis NVS:US $ 9059M 463M
Pacira Pharmaceuticals PCRX:US $ 121.92M 1.73M
Pfizer PFE:US $ 15651M 1516M
Supernus Pharmaceuticals SUPN:US $ 142.06M 11.68M